217 related articles for article (PubMed ID: 21060825)
1. The LARGE principle of cellular reprogramming: lost, acquired and retained gene expression in foreskin and amniotic fluid-derived human iPS cells.
Wolfrum K; Wang Y; Prigione A; Sperling K; Lehrach H; Adjaye J
PLoS One; 2010 Oct; 5(10):e13703. PubMed ID: 21060825
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the retinal potential of embryonic stem cells and amniotic fluid-derived stem cells.
Decembrini S; Cananzi M; Gualdoni S; Battersby A; Allen N; Pearson RA; Ali RR; De Coppi P; Sowden JC
Stem Cells Dev; 2011 May; 20(5):851-63. PubMed ID: 20939691
[TBL] [Abstract][Full Text] [Related]
3. Defining differentially methylated regions specific for the acquisition of pluripotency and maintenance in human pluripotent stem cells via microarray.
He W; Kang X; Du H; Song B; Lu Z; Huang Y; Wang D; Sun X; Yu Y; Fan Y
PLoS One; 2014; 9(9):e108350. PubMed ID: 25250679
[TBL] [Abstract][Full Text] [Related]
4. Direct Reprogramming of Human Amniotic Fluid Stem Cells by OCT4 and Application in Repairing of Cerebral Ischemia Damage.
Qin M; Chen R; Li H; Liang H; Xue Q; Li F; Chen Y; Zhang X
Int J Biol Sci; 2016; 12(5):558-68. PubMed ID: 27019637
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Nanog and Sox-2 genes following ectopic expression of Oct-4 in amniotic fluid mesenchymal stem cells.
Wang KH; Kao AP; Chang CC; Lin TC; Kuo TC
Biotechnol Appl Biochem; 2015; 62(5):591-7. PubMed ID: 25385323
[TBL] [Abstract][Full Text] [Related]
6. Amniotic Fluid Cells Show Higher Pluripotency-Related Gene Expression Than Allantoic Fluid Cells.
Kehl D; Generali M; Görtz S; Geering D; Slamecka J; Hoerstrup SP; Bleul U; Weber B
Stem Cells Dev; 2017 Oct; 26(19):1424-1437. PubMed ID: 28708036
[TBL] [Abstract][Full Text] [Related]
7. High efficiency of reprogramming CD34⁺ cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4.
Liu T; Zou G; Gao Y; Zhao X; Wang H; Huang Q; Jiang L; Guo L; Cheng W
Stem Cells Dev; 2012 Aug; 21(12):2322-32. PubMed ID: 22264161
[TBL] [Abstract][Full Text] [Related]
8. Human Cardiomyocytes Prior to Birth by Integration-Free Reprogramming of Amniotic Fluid Cells.
Jiang G; Herron TJ; Di Bernardo J; Walker KA; O'Shea KS; Kunisaki SM
Stem Cells Transl Med; 2016 Dec; 5(12):1595-1606. PubMed ID: 27465073
[TBL] [Abstract][Full Text] [Related]
9. Low microRNA-199a expression in human amniotic epithelial cell feeder layers maintains human-induced pluripotent stem cell pluripotency via increased leukemia inhibitory factor expression.
Liu T; Chen Q; Huang Y; Huang Q; Jiang L; Guo L
Acta Biochim Biophys Sin (Shanghai); 2012 Mar; 44(3):197-206. PubMed ID: 22285730
[TBL] [Abstract][Full Text] [Related]
10. Term amniotic fluid: an unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications.
Moraghebi R; Kirkeby A; Chaves P; Rönn RE; Sitnicka E; Parmar M; Larsson M; Herbst A; Woods NB
Stem Cell Res Ther; 2017 Aug; 8(1):190. PubMed ID: 28841906
[TBL] [Abstract][Full Text] [Related]
11. Trib2 regulates the pluripotency of embryonic stem cells and enhances reprogramming efficiency.
Do EK; Park JK; Cheon HC; Kwon YW; Heo SC; Choi EJ; Seo JK; Jang IH; Lee SC; Kim JH
Exp Mol Med; 2017 Nov; 49(11):e401. PubMed ID: 29170476
[TBL] [Abstract][Full Text] [Related]
12. Reptin regulates pluripotency of embryonic stem cells and somatic cell reprogramming through Oct4-dependent mechanism.
Do EK; Cheon HC; Jang IH; Choi EJ; Heo SC; Kang KT; Bae KH; Cho YS; Seo JK; Yoon JH; Lee TG; Kim JH
Stem Cells; 2014 Dec; 32(12):3126-36. PubMed ID: 25185564
[TBL] [Abstract][Full Text] [Related]
13. Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG.
Zhao HX; Li Y; Jin HF; Xie L; Liu C; Jiang F; Luo YN; Yin GW; Li Y; Wang J; Li LS; Yao YQ; Wang XH
Differentiation; 2010; 80(2-3):123-9. PubMed ID: 20510497
[TBL] [Abstract][Full Text] [Related]
14. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.
Li C; Zhou J; Shi G; Ma Y; Yang Y; Gu J; Yu H; Jin S; Wei Z; Chen F; Jin Y
Hum Mol Genet; 2009 Nov; 18(22):4340-9. PubMed ID: 19679563
[TBL] [Abstract][Full Text] [Related]
15. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
[TBL] [Abstract][Full Text] [Related]
16. Generation of pig induced pluripotent stem cells using an extended pluripotent stem cell culture system.
Xu J; Yu L; Guo J; Xiang J; Zheng Z; Gao D; Shi B; Hao H; Jiao D; Zhong L; Wang Y; Wu J; Wei H; Han J
Stem Cell Res Ther; 2019 Jun; 10(1):193. PubMed ID: 31248457
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem (iPS) cells from human fetal stem cells.
Guillot PV
Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():112-20. PubMed ID: 26427551
[TBL] [Abstract][Full Text] [Related]
18. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
Gunaratne PH
Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978
[TBL] [Abstract][Full Text] [Related]
19. Generation of iPSC lines from primary human amniotic fluid cells.
Drews K; Matz P; Adjaye J
Stem Cell Res; 2015 Nov; 15(3):712-4. PubMed ID: 26987930
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis reveals the unique stem cell identity of human amniocytes.
Maguire CT; Demarest BL; Hill JT; Palmer JD; Brothman AR; Yost HJ; Condic ML
PLoS One; 2013; 8(1):e53372. PubMed ID: 23326421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
